JNJ

237.86

+1.46%↑

UNH

273.01

-2.38%↓

TMO

560.86

-2.06%↓

ABT

108.19

+0.27%↑

ISRG

481.52

+3.05%↑

JNJ

237.86

+1.46%↑

UNH

273.01

-2.38%↓

TMO

560.86

-2.06%↓

ABT

108.19

+0.27%↑

ISRG

481.52

+3.05%↑

JNJ

237.86

+1.46%↑

UNH

273.01

-2.38%↓

TMO

560.86

-2.06%↓

ABT

108.19

+0.27%↑

ISRG

481.52

+3.05%↑

JNJ

237.86

+1.46%↑

UNH

273.01

-2.38%↓

TMO

560.86

-2.06%↓

ABT

108.19

+0.27%↑

ISRG

481.52

+3.05%↑

JNJ

237.86

+1.46%↑

UNH

273.01

-2.38%↓

TMO

560.86

-2.06%↓

ABT

108.19

+0.27%↑

ISRG

481.52

+3.05%↑

Search

McKesson Corp

Fechado

SetorSaúde

952.58 14.63

Visão Geral

Variação de preço das ações

24h

Atual

Mín

818

Máximo

833.84

Indicadores-chave

By Trading Economics

Rendimento

426M

1.2B

Vendas

5.3B

103B

P/E

Médio do Setor

26.453

84.243

Rendimento de Dividendos

0.35

Margem de lucro

1.173

Funcionários

43,000

EBITDA

212M

1.5B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+16.31% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.35%

2.28%

Próxima data de dividendos

1 de abr. de 2026

Próxima data de ex-dividendo

2 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

3.3B

105B

Abertura anterior

937.95

Fecho anterior

952.58

Sentimento de Notícias

By Acuity

50%

50%

151 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

McKesson Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de fev. de 2026, 00:00 UTC

Ações em Alta

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4 de fev. de 2026, 22:55 UTC

Ganhos

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4 de fev. de 2026, 21:44 UTC

Ganhos

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4 de fev. de 2026, 21:39 UTC

Ganhos

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

5 de fev. de 2026, 00:00 UTC

Ganhos

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

5 de fev. de 2026, 00:00 UTC

Ganhos

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

4 de fev. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4 de fev. de 2026, 23:45 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4 de fev. de 2026, 23:32 UTC

Conversa de Mercado

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4 de fev. de 2026, 22:59 UTC

Aquisições, Fusões, Aquisições de Empresas

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4 de fev. de 2026, 22:30 UTC

Ganhos

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4 de fev. de 2026, 22:30 UTC

Ganhos

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4 de fev. de 2026, 22:21 UTC

Ganhos

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 de fev. de 2026, 22:17 UTC

Conversa de Mercado

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4 de fev. de 2026, 22:15 UTC

Conversa de Mercado

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4 de fev. de 2026, 22:00 UTC

Conversa de Mercado

ESG Roundup: Market Talk

4 de fev. de 2026, 21:53 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4 de fev. de 2026, 21:51 UTC

Ganhos

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

4 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

4 de fev. de 2026, 21:45 UTC

Ganhos

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4 de fev. de 2026, 21:44 UTC

Ganhos

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4 de fev. de 2026, 21:43 UTC

Ganhos

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4 de fev. de 2026, 21:41 UTC

Ganhos

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 de fev. de 2026, 21:36 UTC

Conversa de Mercado

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4 de fev. de 2026, 21:30 UTC

Ganhos

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 de fev. de 2026, 21:30 UTC

Ganhos

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4 de fev. de 2026, 21:30 UTC

Ganhos

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Comparação entre Pares

Variação de preço

McKesson Corp Previsão

Preço-alvo

By TipRanks

16.31% parte superior

Previsão para 12 meses

Média 956.09 USD  16.31%

Máximo 1,012 USD

Mínimo 880 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para McKesson Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

11 ratings

9

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

681.92 / 707.28Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

No Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

151 / 352 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat